Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial).

Amr Abdin,Michel Komajda,Jeffrey S Borer,Ian Ford,Luigi Tavazzi,Cécile Batailler,Karl Swedberg,Giuseppe M C Rosano,Felix Mahfoud,Michael Böhm

ESC heart failure（2023）

引用 1|浏览50

暂无评分

摘要

Our analysis shows that RHR reduction with ivabradine is effective and improves clinical outcomes in HF patients across various risk indicators such as low SBP, high RHR, low LVEF, and high NYHA class to a similar extent and without safety concern.

查看译文

关键词

Heart failure, Ivabradine, Risk indicators, High risk, Heart rate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要